Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Gastroenterology. 2017 Feb 4;152(6):1310–1318.e1. doi: 10.1053/j.gastro.2017.01.042

Table 3.

Primary and Secondary Outcomes Within 30 days

Standard Doppler difference 95%
Confidence
Intervals
lower
95%
Confidence
Intervals
upper
P
value

Patients 76 72

Routine 30 day Outcomes Index Lesion Rebleed 20 (26.3%) 8 (11.1%) 15.2% 2.7% 27.7% 0.021

Surgery for Rebleeds 4 (5.3%) 0 (0%) 5.3% 0.0% 12.8% 0.048

Angiography for Rebleeds 1 (1.3%) 4 (5.6%) −4.2% −12.3% 2.5% 0.200

Death 3 (4.0%) 1 (1.4%) 2.6% −3.9% 9.8% 0.337

Major 4 (5.3%) 0 (0%) 5.3% 0.0% 12.8% 0.048
Complications CVA 2 (2.6%) 0 (0%)
Perforation 1 (1.3%) 0 (0%)
Pneumopertoneum 1 (1.3%) 0 (0%)

Other Gastrointestinal Bleeds 3 (4.0%) 4 (5.6%) −1.6% −10.1% 6.2% 0.714

Transfusions and Hospital Days *

More red cell units transfused 1.09 ± 2.94 0.56 ± 2.41 0.53 −0.34 1.40 0.230

More units of fresh frozen plasma transfused 0.12 ± 0.49 0.06 ± 0.29 0.06 −0.07 0.19 0.502

More unit of platelets transfused 0.03 ± 0.23 0.06 ± 0.33 −0.03 −0.12 0.06 0.890

Hospital Days

Length of Stay in the Intensive care unit (in days) 4.21 ± 8.40 3.04 ± 3.04 1.17 −0.86 3.20 0.220

Length of hospital stay (in days) 7.00 ± 8.79 6.65 ± 8.48 0.35 −2.46 3.16 0.997

Legend.

*

Numerical variables: Mean ± Standard deviation.